REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 59 filers reported holding REGULUS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $0 | -100.0% | 2,000 | -77.5% | 0.00% | – |
Q2 2018 | $6,000 | 0.0% | 8,900 | 0.0% | 0.00% | – |
Q1 2018 | $6,000 | -33.3% | 8,900 | 0.0% | 0.00% | – |
Q4 2017 | $9,000 | -25.0% | 8,900 | 0.0% | 0.00% | – |
Q3 2017 | $12,000 | +33.3% | 8,900 | -5.3% | 0.00% | – |
Q2 2017 | $9,000 | -40.0% | 9,400 | 0.0% | 0.00% | – |
Q1 2017 | $15,000 | +150.0% | 9,400 | +276.0% | 0.00% | – |
Q4 2016 | $6,000 | -33.3% | 2,500 | 0.0% | 0.00% | – |
Q3 2016 | $9,000 | +50.0% | 2,500 | +25.0% | 0.00% | – |
Q2 2016 | $6,000 | -57.1% | 2,000 | 0.0% | 0.00% | – |
Q1 2016 | $14,000 | -17.6% | 2,000 | 0.0% | 0.00% | – |
Q4 2015 | $17,000 | +30.8% | 2,000 | 0.0% | 0.00% | – |
Q3 2015 | $13,000 | -40.9% | 2,000 | 0.0% | 0.00% | – |
Q2 2015 | $22,000 | -35.3% | 2,000 | 0.0% | 0.00% | -100.0% |
Q1 2015 | $34,000 | +6.2% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $32,000 | -5.9% | 2,000 | -60.0% | 0.00% | 0.0% |
Q3 2014 | $34,000 | -15.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $40,000 | -11.1% | 5,000 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $45,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 327,350 | $2,943,000 | 1.62% |
HealthCor Management, L.P. | 1,575,000 | $14,207,000 | 0.86% |
Cormorant Asset Management, LP | 200,000 | $1,804,000 | 0.42% |
BVF INC/IL | 184,999 | $1,669,000 | 0.26% |
Verity Asset Management, Inc. | 28,410 | $244,000 | 0.25% |
Callan Capital, LLC | 80,478 | $726,000 | 0.24% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 225,000 | $2,029,000 | 0.22% |
EMERALD MUTUAL FUND ADVISERS TRUST | 61,846 | $558,000 | 0.05% |
LMR Partners LLP | 11,815 | $106,000 | 0.02% |
Weiss Multi-Strategy Advisers LLC | 70,000 | $631,000 | 0.01% |